June 12, 2024

Lenire®, the treatment device shown to reduce tinnitus symptoms in 95% of patients, is now available in Hungary – PR Newswire

More than 1 million Hungarians could experience tinnitus
Tinnitus Klinika’s 3 clinics will provide Lenire throughout Hungary
Availability in Hungary follows publication of second large-scale clinical trial results, showing greater improvement in tinnitus symptoms

BUDAPEST, Hungary, Sept. 29, 2022 /PRNewswire/ — Irish medical device company, Neuromod Devices Ltd., which specialises in the treatment of tinnitus, has reached an agreement with Tinnitus Klinika kft, a provider of specialist tinn…….

  • More than 1 million Hungarians could experience tinnitus
  • Tinnitus Klinika’s 3 clinics will provide Lenire throughout Hungary
  • Availability in Hungary follows publication of second large-scale clinical trial results, showing greater improvement in tinnitus symptoms

BUDAPEST, Hungary, Sept. 29, 2022 /PRNewswire/ — Irish medical device company, Neuromod Devices Ltd., which specialises in the treatment of tinnitus, has reached an agreement with Tinnitus Klinika kft, a provider of specialist tinnitus care, to make its Lenire device available in Hungary.

Tamás Nagy, CEO & Owner of Tinnitus Klinika

Tinnitus patient using Lenire

Lenire is a bimodal neuromodulation device which has shown in analysis of real-world patients and multiple large-scale clinical trials to reduce the severity of tinnitus symptoms. Tinnitus, commonly known as “ringing in the ears”, is a complex neurological condition resulting in the perception of sound without an external source.

Landmark research into the prevalence of tinnitus in Europe was published in renowned scientific journal, The Lancet, in late 2021. It found that prevalence of any tinnitus was 14.7%i, which could mean that 1.4 million Hungarians experience the condition. 

Through this distribution agreement, Tinnitus Klinika’s specialist team has exclusive licence from Neuromod to provide Lenire throughout Hungary to suitable patients for the treatment of their tinnitus.

“I’m delighted to work with Tinnitus Klinika to make Lenire available to people living with tinnitus in Hungary. Tinnitus is globally recognised as a significant healthcare challenge and many people living with the condition have unmet clinical needs. Tinnitus specialists like Tinnitus Klinika deeply understand the needs of tinnitus patients and we’re proud to be able to support them in improving therapeutic outcomes for their patients,” explains Dr Ross O’Neill, Founder and CEO of Neuromod Devices.

In the last 12 months Neuromod has expanded availability of Lenire in Europe, launching it in Denmark, Norway, Spain, Switzerland, and the UK. Earlier in 2022 the results of an independent real-world analysis were published in the peer-reviewed scientific journal, Brain Stimulation, demonstrating the safety and efficacy of the Lenire device for improving symptoms in tinnitus patients. The study found that 85% of tinnitus patients experienced a reduction in their tinnitus symptoms, as measured by THIii, following six to 12 …….

Source: https://www.prnewswire.com/news-releases/lenire-the-treatment-device-shown-to-reduce-tinnitus-symptoms-in-95-of-patients-is-now-available-in-hungary-301636150.html